Welcome to New Medicine

We develop smart health systems by translating advanced science and technology into effective practice.

Featured

Jul 5, 2018

New Medicine Partners present a strategy of personalised medicine for healthy longevity of Kazakh nation in Astana

Jul 5, 2018

On 5 July 2018 Professor Richard Barker, Founder and Director of NMP and the Scientific Director of the programme, presented Personalised Medicine Development Strategy for Healthy Longevity of Kazakhstan Nation to a group of Kazakhstan government representatives, investors and global public policy experts at a special event in Astana.

Jul 5, 2018

We are a solution providers working with health systems around the world. Our mission is to enable people to live healthily for longer by accelerating the development and application of precision medicine technologies.

Precision medicine is about using technology to target healthcare interventions more effectively at both an individual and a population level. This approach integrates a range of tools: prognostics to detect health risks early; digital tools to promote patient empowerment; diagnostics to better characterise health or disease states; and targeted therapeutics and interventions.

Precision medicine technologies enable more efficient allocation of resources. They will enable health systems to become 'smarter', more streamlined, and ultimately deliver better health outcomes.

Opportunities for -

Health Systems | Technology Providers | Investors | Global Health Organisations

Health Systems

We work closely with national and regional systems to identify and implement the right precision medicine technologies. Our focuses include: addressing key disease burdens; increasing health system efficiency; advancing the healthy lifespan at a population level; and life science industry development.

Technology Providers

We create fast-track development and market access strategies for precision medicine technologies within health systems around the world. Our global expertise enables matching of technology solutions with national and regional disease priorities, opportunities for efficiency gains, and availability of skilled individuals for implementation.

Investors

We source the best precision medicine solutions from around the world, assess their readiness for investment and identify the optimum locations for their development. Our goal is a robust portfolio of growth technologies that will lead the transition to precision medicine in many national systems over the next decade, and we support investors seeking to include such technologies within their portfolios.

Global Health Organisations

We collaborate in the development and application of globally applicable precision medicine solutions. Our work is focused on enabling less developed and middle-income nations to leapfrog the problems challenging more developed health systems. We build systems that anticipate disease, intervene early and manage proactively.

The latest insights from New Medicine Partners

Insights from New Medicine Partners

Metabesity: How can 21st-century medicine fight 'a very 21st-century crisis'

Metabesity, a newly coined term that describes the plethora of obesity-related metabolic disorders, will cost the world economy 1.2 trillion US dollars by 2025 and affect more population groups if remains unsolved. What can 21st-century medicine offer to address this global issue?

What does precision medicine mean to developing economy health systems?

‘Precision medicine’ (PM) to many people implies expensive genomic testing followed by even more expensive drug therapy. Understandably many developing economies believe that this kind of PM is not for them—not yet at any rate. Or at least, not for the general population.

What is Precision Medicine?

New Medicine Parters Founder Professor Richard Barker talks about his vision for the future of precision medicine and the challenge of turning huge research projects into routine medical practice. Professor Barker is the author of Bioscience - Lost in Translation?, which provides readers with a global context to problem of effective translation of biomedical research into health system improvements.

Bioscience: Lost in Translation? (book excerpt)

At the heart of this book is a mystery. Our everyday experience is of accelerating innovation in many areas that touch our lives. In information technology (IT) and services, we live in an exponential age. But in the area of perhaps our greatest interest—our health—innovation seems stubbornly slow. Before we dive into the mystery further, let us step back and ask some basic questions. What is true innovation? And are we really living in an innovative society?

Smarter Health Systems

We believe that traditional health systems are unsustainable. As populations age and chronic diseases multiply, designing systems that treat patients as passive recipients, diagnose their diseases once symptoms have developed and intervene via expensive therapies is a path to ‘medical meltdown’.

Advanced Therapeutics and Chronic Disease Management

A new wave of therapies are emerging. These technologies don’t simply mask symptoms and provide palliative care, but leverage our own biology to target interventions and even cure the previously incurable. ‘Advanced Therapies’ include gene therapies, stem cell therapies and tissue engineered products. These technologies have the capability to target fundamental disease mechanisms, ultimately extending healthy lifespan; in 2030 you might be opting for genetic ‘surgery’, or cellular ‘medicine’ as opposed to popping a pill.

On Healthy Lifespan

Human longevity is now the subject of numerous scientific papers, magazine articles, international conferences, technology fairs, and earnest seminars among finance executives. There seems no consensus on whether it is a ‘good thing’ since some of the consequences of greater population aging are clearly problematic – for example greater dependency ratios: greater imbalance between those requiring support from the state and those contributing to it.

Healthcare in growing economies

Most middle-income countries will be expanding their health systems and expenditure over the coming decade. However they see that even countries with high GDP per capita and relatively high share of GDP on health are struggling to make their systems sustainable. How best to focus the additional spend to avoid the problems that all developed countries are encountering?

Bioscience-Lost in Translation?

Precision Medicine holds the key to health system transformation. Professor Richard Barker's latest book - Bioscience-Lost in Translation? - highlights the global problem of the ineffective translation of bioscience innovation into health system improvements and its consequences, analyses the underlying causative factors and provides powerful prescriptions for change to close the gap. It contrasts the progress in biomedicine with other areas of scientific and technological endeavour, such as information technology, in which there are faster and more reliable returns for society.